BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21255524)

  • 1. Total control of asthma: an evaluation in patients of a tertiary hospital.
    Becerril Angeles M; Martínez Castro JE
    Rev Alerg Mex; 2010; 57(4):123-6. PubMed ID: 21255524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of sex to asthma prevalence, health care utilization, and medications in a large managed care organization.
    Schatz M; Camargo CA
    Ann Allergy Asthma Immunol; 2003 Dec; 91(6):553-8. PubMed ID: 14700439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of asthma control in tertiary level in Turkey: a cross-sectional multicenter survey.
    Turktas H; Mungan D; Uysal MA; Oguzulgen K;
    J Asthma; 2010 Jun; 47(5):557-62. PubMed ID: 20560829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between asthma drug therapy patterns and healthcare utilization.
    Shireman TI; Heaton PC; Gay WE; Cluxton RJ; Moomaw CJ
    Ann Pharmacother; 2002 Apr; 36(4):557-64. PubMed ID: 11918499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factors influencing asthma course and the degree of control in the patients assessed with own questionnaire and Asthma Control Test (ACT)].
    Krasnodębska P; Hermanowicz-Salamon J; Domagała-Kulawik J; Chazan R
    Pneumonol Alergol Pol; 2012; 80(3):198-208. PubMed ID: 22562271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-course montelukast for intermittent asthma in children: a randomized controlled trial.
    Robertson CF; Price D; Henry R; Mellis C; Glasgow N; Fitzgerald D; Lee AJ; Turner J; Sant M
    Am J Respir Crit Care Med; 2007 Feb; 175(4):323-9. PubMed ID: 17110643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of Mexican asthmatic subjects attending an outpatient service].
    Fernández-Vega M; Vargas MH; Regalado-Pineda J; Chapela-Mendoza R; Salas-Hernández J
    Rev Invest Clin; 2005; 57(4):513-21. PubMed ID: 16315635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of asthma control: the SERENA study.
    Corrado A; Renda T; Polese G; Rossi A;
    Respir Med; 2013 Nov; 107(11):1659-66. PubMed ID: 24045118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asthma control in Canada: no improvement since we last looked in 1999.
    McIvor RA; Boulet LP; FitzGerald JM; Zimmerman S; Chapman KR
    Can Fam Physician; 2007 Apr; 53(4):672-7. PubMed ID: 17872718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled anti-inflammatory pharmacotherapy and subsequent hospitalizations and emergency department visits among patients with asthma in the Texas Medicaid program.
    Smith MJ; Rascati KL; McWilliams BC
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):40-6. PubMed ID: 14756463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the effects of omalizumab over 5 years among patients with moderate-to-severe persistent allergic asthma.
    Grossman HL; Schlender A; Alperin P; Stanley EL; Zhang J
    Curr Med Res Opin; 2010 Dec; 26(12):2779-93. PubMed ID: 21050061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS; Yawn BP
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of omalizumab on emergency-department visits, hospitalizations, and corticosteroid use among patients with uncontrolled asthma.
    Lafeuille MH; Dean J; Zhang J; Duh MS; Gorsh B; Lefebvre P
    Ann Allergy Asthma Immunol; 2012 Jul; 109(1):59-64. PubMed ID: 22727159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High use of health services in patients with suboptimal asthma drug regimens: a population-based assessment in British Columbia, Canada.
    Zhang T; Smith MA; Camp PG; Carleton BC
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):744-51. PubMed ID: 23559540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population.
    Piecoro LT; Potoski M; Talbert JC; Doherty DE
    Health Serv Res; 2001 Jun; 36(2):357-71. PubMed ID: 11409817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ratio of controller to total asthma medications: determinants of the measure.
    Broder MS; Gutierrez B; Chang E; Meddis D; Schatz M
    Am J Manag Care; 2010 Mar; 16(3):170-8. PubMed ID: 20225912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled steroid therapy and hospitalization for bronchial asthma: trend in Tokushima University Hospital.
    Yanagawa H; Shiraga M; Nakamura Y; Azuma M; Yoneda K; Ogawa H; Kitamuro C; Maeda K; Miki M; Matsumori Y; Sugita A; Hashimoto S; Hara C; Tani K; Sone S
    J Med Invest; 2003 Feb; 50(1-2):72-7. PubMed ID: 12630571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma.
    Fuhlbrigge AL; Weiss ST; Kuntz KM; Paltiel AD;
    Pediatrics; 2006 Aug; 118(2):e347-55. PubMed ID: 16864642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Asthma control status in Tunisia].
    Aissa I; Gharsalli H; Khattab A; Driss L; Ghedira H
    Tunis Med; 2010 Feb; 88(2):97-101. PubMed ID: 20415167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between consistent omalizumab treatment and asthma control.
    Lafeuille MH; Gravel J; Zhang J; Gorsh B; Figliomeni M; Lefebvre P
    J Allergy Clin Immunol Pract; 2013 Jan; 1(1):51-7. PubMed ID: 24229822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.